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Abstract: 
Objectives: they studied the relations of genetic polymorphisms with the risk of preeclampsia occurrence depending 
on hereditary complication. 
Materials and Methods: The study was conducted in two groups of pregnant women: 274 women diagnosed with 
preeclampsia and 179 women with physiological gestation. They studied seven polymorphisms of folate cycle genes 
(+677ɋ>Ɍ MɌHFR (rs1801133), +1298А>ɋ MɌHFR (rs1801131), + 66А>G MɌRR (rs1801394), + 2756А>G 
MɌR (rs1805087), -1053ɋ>Ɍ ɌYMS (rs699517), IVS 6-68 C>T TYMS (rs1059394), -1122A>G TYMS (rs2790)) by 
real-time method of polymerase chain reaction (PCR) in DNA synthesis (Real-time-PCR). 
Results: The frequencies of alleles +2756G MTR and the genotype +2756GG MTR were higher in the group of 
pregnant women with preeclampsia without hereditary complication, as compared with the pregnant women of 
control group (OR = 1.61, p = 0.01, OR = 7.26, p = 0.0007, pbonf = 0.0021, respectively). 
Conclusions: Thus, the polymorphism of methionine synthase gene + 2756A>G MɌR is associated with the risk of 
preeclampsia occurrence depending on the presence of a complicated family anamnesis.. 
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INTRODUCTION: 
Preeclampsia (PE) - is a complication of pregnancy, 
characterizing by the arterial hypertension, 
proteinuria, oedemata, as well as by deep disorders of 
the vascular system, hemostasis, immunity, 
hemodynamics and microcirculation, fetoplacental 
insufficiency, kidney, hepatic and lungs 
malfunctions.(Hayashi et al, 2007; Sidorova, 
Nikitina, 2014). 
 
The prevalence of preeclampsia is 4-18% among all 
pregnant women (Clark et al, 2008), and the perinatal 
mortality rate is 23-27% (Trunova et al., 2011). 
 
An important role in the etiology and pathogenesis of 
preeclampsia belongs to the folate candidate genes 
(Vorozhinceva, 2014, Xiaoming et al, 2015, Zhou et 
al, 2016). Mutations in the genes of folate 
metabolism, causing the decrease in the activity of 
enzymes of methyltetrahydrofolatereductase and 
methionine synthase reductase, lead to accumulation 
of homocysteinein the body of a pregnant woman, 
and to a deficiency of folic acid (Vorozhinceva, 2014; 
Xiaoming et al, 2015). Deficiency of folic acid 
affects the proliferation of chorionic cells and the 
formation of placenta. This complicates the course of 
gestation, increasing the risk of placental 
insufficiency, preeclampsia and other disorders of 
prenatal development. The role of candidate genes of 
folate metabolism in the formation of PE is actively 
studied, but these studies often give conflicting 
results for different populations (Obolenska et al, 
2011; Pavlova et al, 2011; Williams et al, 2011; 
Valenzuela et al, 2012; Vorozhinceva, 2014; Reilly et 
al, 2014; Xiaoming et al, 2015). 
 
MATERIALS AND METHODS: 
Object of study 
The study group included 274 pregnant women, 
diagnosed with preeclampsia (105 of them with 
hereditary burden for preeclampsia, 169 pregnant 
women without genetic predisposition to 
preeclampsia) and 179 women with normal course of 
gestation. The average age of women with PE was 
27.19 ± 6.4, in the control group - 26.71 ± 6.36. All 
clinical studies were carried out according to the 
protocols of ethical committee of the Russian 
Federation, with the informed consent of patients. 
The criteria for inclusion in the study were the 
following: Russian nationality, the absence of 
kinship, living in the Central Black Earth region of 
Russia. 
 
The exclusion criteria for the sample formation were 
the following: uterine pathology, pathology of 
pregnancy, fetal pathology, multifetal pregnancy. 
 
Preeclampsia was diagnosed by the presence of 
arterial hypertension, proteinuria and generalized 
oedemata (Turner, 2010). 
 
Molecular and genetic methods 
Typing of the following polymorphic variants of 
folate cycle genes was carried out for all pregnant 
women with preeclampsia and pregnant women from 
the control group: 
methylenetetrahydrofolatereductase (+677ɋ>Ɍ 
MɌHFR (rs1801133), +1298А>ɋMɌHFR 
(rs1801131)), methionine synthase reductase (+ 
66А>G MɌRR (rs1801394)), methionine synthase 
(+2756A>G MTR (rs1805087)), 
thymidylatesynthetase (-1053ɋ>Ɍ ɌYMS (rs699517), 
IVS 6-68 ɋ>ɌɌYМS (rs1059394), -1122А>G ɌYMS 
(rs2790)). All polymorphic variants of folate cycle 
enzymes were analyzed using the method of 
polymerase chain reaction (PCR) of DNA synthesis 
in real-time (Real-time-PCR). 
 
Statistical methods 
Gene and phenotypic frequencies were calculated 
using the standard methods. The conformity of the 
observed distribution of genotypes to the expected 
one, according to the Hardy-Weinberg equilibrium, 
was performed using the χ2 criterion. The Bonferroni 
correction was used when carrying out multiple 
comparisons. 
The associations of alleles and genotypes of 
the studied polymorphic variants with the formation 
of preeclampsia were assessed using 2×2 conjugation 
tables, with calculation of χ2 criterion, with the Yates 
correction for continuity and odds ratio (OR), with 
95% confidence interval (Schlesselman J., 1982). 
 
RESULTS: 
Significant differences were not revealed in the 
process of comparative analysis of the frequency 
distribution of alleles and genotypes of polymorphic 
markers of folate cycle genes in the group of 
pregnant women with PE, having hereditary burden, 
and in the group of healthy pregnant women (taking 
into account the Bonferroni correction). 
In the group of pregnant women with preeclampsia, 
without hereditary burden, high frequencies of alleles 
+ 2756G MTR (33.73%), IVS6-68T TYMS (29.01%) 
and the genotype + 2756GG MTR (15.53%) were 
found, in comparison with the pregnant women from 
the control group (21.30%, ОR=1.61; 95%ɋI 1.12-
2.31; χ2=6.87; p=0.01; 21.50%, ОR=1.49; 95%ɋI 
1.02-2.18; χ2=4.31; p=0.04; 2.47%, ОR=7.26; 95%ɋI 
2.32-25.29; χ2=15.29; p=0.0007, pbonf=0.0021).  
 
When using Bonferronicorrection, the differences 
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between pregnant women with PE, without a 
burdened familial history, and pregnant women from 
the control group were statistically not significant for 
the genotype IVS6-68TT TYMS. 
 
DISCUSSION: 
The results of this study show, that polymorphism of 
the methionine synthase gene +2756A>G MTR has 
significant pathogeneticimportance for the occurrence 
of preeclampsia. The allele +2756G MTR and the 
genotype +2756GG MTR are associated with a risk of 
preeclampsia in pregnant women without a burdened 
familial history. 
 
Methionine synthase (MTR) is one of the most 
important enzymes of folate metabolism. This 
cytoplasmic enzyme catalyzes the reaction of 
homocysteine methylation,  with its conversion to 
methionine, using 5-methyltetrahydrofolate as a 
donor of the methyl group, thereby reducing the 
concentration of homocysteinein blood. The 
polymorphism of the gene +2756A>G MTR is 
associated with the replacement of asparagine to 
glycine at the 919 position of the protein, that may 
affect its secondary structure, and therefore has a 
functional significance (Furness et al, 2008). 
 
In other studies on the search for associations of 
folate cycle genes with the risk of preeclampsia, 
opposite results were obtained. Thus, in the studies 
on the Polish, Spanish and South American 
populations, there was no association of 
polymorphism of gene +2756A>G MTR with the risk 
of preeclampsia development (Also-Rallo et al, 2005, 
Pérez-Sepúlveda et al, 2013, Seremak-Mrozikiewicz 
et al, 2017). 
 
The  inconsistency of the results, obtained in 
various studies, may be related to the differences in 
the ethnic and, respectively, genetic background of 
the studied populations (Churnosov et al., 2005; 
Sorokina et al., 2007; Xiaoming et al, 2015). Even 
the population of certain regional groups of Russians 
(Belgorod region, the south of Central Russia, the 
center of Central Russia) is so genetically diverse, as 
some of the nations of Western Europe (Germans, 
Norwegians, etc.) and is significantly higher, than the 
variability of most ethnic Slavic groups (Bulgarians, 
Czechs, Poles) (Churnosov et al., 2005; Sorokina et 
al., 2007). This feature of the Russian gene pool 
determines the need to take into account the 
population sample, for which the results are obtained. 
 
SUMMARY: 
Thus, as a result of this study, significant associations 
of polymorphism of the gene +2756A>G MTR with 
the risk of preeclampsia were established, depending 
on the burdened familial history. 
 
CONCLUSION: 
The data, obtained in the process of the research, will 
make it possible to form risk groups of preeclampsia 
at the preclinical stage, and to carry out effective 
preventive measures in these groups. On the other 
hand, it will allow to predict the nature of the clinical 
course of disease among patients, that will optimize 
the therapeutic-diagnostic process for each patient. 
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